Latest Articles
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology
Published: Jan. 5, 2026, 1:07 p.m.
Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts - Inshorts
Does menopause increase endometrial cancer risk? | Tap to know more | Inshorts Inshorts
Published: Jan. 4, 2026, 7:43 a.m.
FBXW7 Identified as Key Regulator of M2 Macrophage Polarization in Endometrial Cancer - geneonline.com
FBXW7 Identified as Key Regulator of M2 Macrophage Polarization in Endometrial Cancer geneonline.com
Published: Jan. 4, 2026, 6:37 a.m.
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer - Bioengineer.org
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer Bioengineer.org
Published: Jan. 4, 2026, 5:52 a.m.
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer - BIOENGINEER.ORG
FBXW7 Modulates M2 Macrophage Polarization in Endometrial Cancer BIOENGINEER.ORG
Published: Jan. 4, 2026, 5:52 a.m.
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer - Oncodaily
Kristina Lindemann: The Prognostic Value of Preoperative ctDNA Assessment in Endometrial Cancer Oncodaily
Published: Jan. 3, 2026, 8:59 p.m.
Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility - OncLive
Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility OncLive
Published: Jan. 2, 2026, 1:12 p.m.
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations - OncLive
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations OncLive
Published: Jan. 2, 2026, 1:10 p.m.
Link copied to clipboard!